Bridgewater Associates’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-49,416
| Closed | -$1.26M | – | 780 |
|
|
2024
Q4 | $1.26M | Buy |
+49,416
| New | +$1.26M | 0.01% | 483 |
|
|
2024
Q3 | – | Sell |
-238,991
| Closed | -$6.3M | – | 905 |
|
|
2024
Q2 | $6.3M | Sell |
238,991
-132,471
| -36% | -$3.49M | 0.03% | 316 |
|
|
2024
Q1 | $11.3M | Buy |
371,462
+350,314
| +1,656% | +$10.6M | 0.06% | 237 |
|
|
2023
Q4 | $594K | Sell |
21,148
-172,028
| -89% | -$4.83M | ﹤0.01% | 690 |
|
|
2023
Q3 | $5.24M | Buy |
193,176
+80,538
| +72% | +$2.19M | 0.03% | 357 |
|
|
2023
Q2 | $3.46M | Buy |
112,638
+79,201
| +237% | +$2.43M | 0.02% | 379 |
|
|
2023
Q1 | $1.2M | Sell |
33,437
-5,656
| -14% | -$204K | 0.01% | 539 |
|
|
2022
Q4 | $1.54M | Sell |
39,093
-22,759
| -37% | -$899K | 0.01% | 573 |
|
|
2022
Q3 | $2.49M | Buy |
61,852
+56,543
| +1,065% | +$2.27M | 0.01% | 515 |
|
|
2022
Q2 | $223K | Sell |
5,309
-35,178
| -87% | -$1.48M | ﹤0.01% | 966 |
|
|
2022
Q1 | $1.58M | Buy |
40,487
+34,739
| +604% | +$1.35M | 0.01% | 726 |
|
|
2021
Q4 | $229K | Buy |
+5,748
| New | +$229K | ﹤0.01% | 716 |
|
|
2021
Q3 | – | Sell |
-18,347
| Closed | -$752K | – | 782 |
|
|
2021
Q2 | $752K | Buy |
+18,347
| New | +$752K | ﹤0.01% | 614 |
|
|
2021
Q1 | – | Sell |
-13,535
| Closed | -$677K | – | 587 |
|
|
2020
Q4 | $677K | Buy |
+13,535
| New | +$677K | 0.01% | 432 |
|